Clinical researchers at the Erasmus University Medical Centre in Rotterdam, the Netherlands, will use Roche and Caliper Life Sciences' combined automated target enrichment platform for a new 3,000-sample exome sequencing study, the partners said this week.

Under the agreement, the Genetic Laboratory of the Department of Internal Medicine at EUMC will use the combined Roche-Caliper offering as part of a new phase of the Rotterdam Study, a large, prospective human epidemiological cohort to characterize and analyze age-related disorders and their risk factors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.